Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Moodys
Cantor Fitzgerald
Dow
McKesson
Accenture
QuintilesIMS
US Department of Justice
Healthtrust

Generated: January 23, 2018

DrugPatentWatch Database Preview

FLOMAX Drug Profile

« Back to Dashboard

When do Flomax patents expire, and what generic alternatives are available?

Flomax is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

US Patents and Regulatory Information for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FLOMAX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Capsules 0.4 mg ➤ Subscribe 12/20/2004

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Federal Trade Commission
Cantor Fitzgerald
Medtronic
Healthtrust
Chubb
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot